205 related articles for article (PubMed ID: 4843162)
21. The inhibition of DNA synthesis by cannabinoids.
Carchman RA; Harris LS; Munson AE
Cancer Res; 1976 Jan; 36(1):95-100. PubMed ID: 1248011
[TBL] [Abstract][Full Text] [Related]
22. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.
Washburn LC; Carlton JE; Hayes RL
Radiat Res; 1974 Aug; 59(2):475-83. PubMed ID: 4371539
[No Abstract] [Full Text] [Related]
23. [Circadian rhythms of DNA synthesis and apoptosis correlated gene expression in bone marrow cells of nude mice bearing human nasopharyngeal carcinoma].
Sun J; Xian LJ; Cao QY; Ye YL; Zeng ZL; Liu XH; Li XM; Levi F
Ai Zheng; 2002 Aug; 21(8):833-7. PubMed ID: 12478887
[TBL] [Abstract][Full Text] [Related]
24. Cell population kinetics of transplanted and metastatic Lewis lung carcinoma.
Simpson-Herren L; Sanford AH; Holmquist JP
Cell Tissue Kinet; 1974 Jul; 7(4):349-61. PubMed ID: 4844546
[No Abstract] [Full Text] [Related]
25. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
Thayer PS; Himmelfarb P; Roberts D
Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
[No Abstract] [Full Text] [Related]
26. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
27. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
Poser RG; Sirotnak FM; Chello PL
Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
[TBL] [Abstract][Full Text] [Related]
28. Natural resistance to methotrexate in human acute nonlymphocytic leukemia.
Bertino JR; Sawicki WL; Cashmore AR; Cadman EC; Skeel RT
Cancer Treat Rep; 1977 Jul; 61(4):667-73. PubMed ID: 267508
[No Abstract] [Full Text] [Related]
29. Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
Young RC
Cancer Treat Rep; 1976 Dec; 60(12):1947-58. PubMed ID: 1026349
[No Abstract] [Full Text] [Related]
30. In vivo methotrexate transport in murine Lewis lung tumor.
Yang KH; Fung WP; Lutz RJ; Dedrick RL; Zaharko DS
J Pharm Sci; 1979 Aug; 68(8):941-5. PubMed ID: 480171
[TBL] [Abstract][Full Text] [Related]
31. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
[TBL] [Abstract][Full Text] [Related]
32. Prediction of methotrexate responsiveness of tumors in man.
Bertino JR; Hryniuk WM; Capizzi R
Natl Cancer Inst Monogr; 1971 Dec; 34():179. PubMed ID: 5291100
[No Abstract] [Full Text] [Related]
33. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
Csányi E; Halász M
Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
[No Abstract] [Full Text] [Related]
34. Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Dobrossy L; Pavelic ZP; Vaughan M; Porter N; Bernacki RJ
Cancer Res; 1980 Sep; 40(9):3281-5. PubMed ID: 7427942
[TBL] [Abstract][Full Text] [Related]
35. Effects of surgery on the cell kinetics of residual tumor.
Simpson-Herren L; Sanford AH? ; Holmquist JP
Cancer Treat Rep; 1976 Dec; 60(12):1749-60. PubMed ID: 1026333
[TBL] [Abstract][Full Text] [Related]
36. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
Schwartz HS
Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
[No Abstract] [Full Text] [Related]
37. Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
Biomedicine; 1977 Jul; 27(5):203-8. PubMed ID: 922120
[No Abstract] [Full Text] [Related]
38. Cell population kinetics and chemotherapy. I. The kinetics of tumor cell populations.
Steel GG; Lamerton LF
Natl Cancer Inst Monogr; 1969 May; 30():29-42. PubMed ID: 5351827
[No Abstract] [Full Text] [Related]
39. [Ribamidyl (ribavirin) as a modulator of the biological action of arabinosylcytosine and methotrexate].
Lobova TG; Zharkov SA; Preobrazhenskaia MN; Garin AM
Eksp Onkol; 1985; 7(3):63-5. PubMed ID: 4017935
[TBL] [Abstract][Full Text] [Related]
40. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
Roberts D; Wodinsky I
Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
